XML 76 R62.htm IDEA: XBRL DOCUMENT v3.24.1
SCHEDULE OF DEFERRED TAX ASSETS (Details) - USD ($)
Dec. 31, 2023
Dec. 31, 2022
Income Tax Disclosure [Abstract]    
Net operating loss carry forwards $ 12,467,570 $ 6,818,547
Research and development costs 2,119,193 707,076
Stock compensation expense 711,598 232,250
Accrued expenses 528,148
Lease liability 512,668
Contingent liability 221,028
Acquisition liability 176,629
Bad debt and other reserves 129,924 92,286
Inventory reserves 109,176 43,678
Other temporary differences 203,340 26,102
Total deferred tax assets 17,179,274 7,919,939
Depreciation and amortization (6,180,688) (5,919,626)
Right of Use assets (487,402)
Accrued expenses (424,423) (26,903)
Contingent liability (130,802)
Other temporary differences (166,712)
Valuation allowance (9,789,247) (1,973,410)
Net deferred tax asset